BeiGene, Ltd. logo
BeiGene, Ltd. BGNE

Geschäftsbericht 2025
hinzugefügt 26.02.2026

report update icon

BeiGene, Ltd. Langfristiger Schuldenstrom 2011-2026 | BGNE

Langfristiger Schuldenstrom Jährlich BeiGene, Ltd.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
20.7 M 17.6 M 22 M 24 M 21.9 M 13.9 M 10.8 M 8.73 M 9.22 M - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
24 M 8.73 M 16.5 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Altimmune Altimmune
ALT
256 K $ 3.44 2.99 % $ 303 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 218.06 -1.72 % $ 5 B danmarkDanmark
Amgen Amgen
AMGN
135 M $ 349.77 0.57 % $ 188 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 19.23 -1.38 % $ 899 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
2.15 M $ 14.6 0.76 % $ 6.06 B irlandaIrlanda
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.4 2.19 % $ 357 M britainBritain
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
ChemoCentryx ChemoCentryx
CCXI
2.81 M - - $ 3.74 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.63 0.77 % $ 16.5 M usaUSA
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
203 K - -74.18 % $ 955 K usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
354 K $ 11.19 1.91 % $ 461 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
547 K $ 4.42 4.25 % $ 734 M canadaCanada
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Brickell Biotech Brickell Biotech
BBI
49 K - -5.38 % $ 6.06 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 2.82 -4.08 % $ 3.29 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
1.37 M - -10.95 % $ 876 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Cara Therapeutics Cara Therapeutics
CARA
1.92 M - -3.03 % $ 260 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA